Cogent Biosciences Statistics
Total Valuation
COGT has a market cap or net worth of $584.48 million. The enterprise value is $355.91 million.
Important Dates
The last earnings date was Tuesday, May 6, 2025, before market open.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
COGT has 113.93 million shares outstanding. The number of shares has increased by 113.09% in one year.
| Current Share Class | 113.86M |
| Shares Outstanding | 113.93M |
| Shares Change (YoY) | +113.09% |
| Shares Change (QoQ) | +1.73% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 81.64% |
| Float | 84.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.94 |
| P/TBV Ratio | 5.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.13, with a Debt / Equity ratio of 0.08.
| Current Ratio | 5.13 |
| Quick Ratio | 4.98 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -84.04% and return on invested capital (ROIC) is -53.27%.
| Return on Equity (ROE) | -84.04% |
| Return on Assets (ROA) | -47.45% |
| Return on Invested Capital (ROIC) | -53.27% |
| Return on Capital Employed (ROCE) | -123.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.31M |
| Employee Count | 205 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.14% in the last 52 weeks. The beta is 0.22, so COGT's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -32.14% |
| 50-Day Moving Average | 5.77 |
| 200-Day Moving Average | 8.60 |
| Relative Strength Index (RSI) | 49.40 |
| Average Volume (20 Days) | 1,271,829 |
Short Selling Information
The latest short interest is 14.68 million, so 12.89% of the outstanding shares have been sold short.
| Short Interest | 14.68M |
| Short Previous Month | 14.33M |
| Short % of Shares Out | 12.89% |
| Short % of Float | 17.35% |
| Short Ratio (days to cover) | 9.34 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -288.47M |
| Pretax Income | -227.05M |
| Net Income | -269.50M |
| EBITDA | -285.98M |
| EBIT | -288.47M |
| Earnings Per Share (EPS) | -$2.04 |
Full Income StatementBalance Sheet
The company has $245.66 million in cash and $17.09 million in debt, giving a net cash position of $228.57 million or $2.01 per share.
| Cash & Cash Equivalents | 245.66M |
| Total Debt | 17.09M |
| Net Cash | 228.57M |
| Net Cash Per Share | $2.01 |
| Equity (Book Value) | 219.00M |
| Book Value Per Share | 0.97 |
| Working Capital | 203.57M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$221.77 million and capital expenditures -$1.05 million, giving a free cash flow of -$222.82 million.
| Operating Cash Flow | -221.77M |
| Capital Expenditures | -1.05M |
| Free Cash Flow | -222.82M |
| FCF Per Share | -$1.96 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |